Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1983 Nov;80(3):587–594. doi: 10.1111/j.1476-5381.1983.tb10733.x

Characterization of the locomotor stimulant action of nicotine in tolerant rats.

P B Clarke, R Kumar
PMCID: PMC2044999  PMID: 6640208

Abstract

Tests of locomotor activity (photocell cages) were used to investigate the development of tolerance to nicotine in rats. Repeated exposure to the apparatus did not influence the rate at which tolerance was acquired. Comparisons of (+)-nicotine (0.4-1.6 mg kg-1, s.c.) and (-)-nicotine (0.1-0.4 mg kg-1, s.c.) in tolerant rats showed that the (-)-isomer was at least ten times more potent in stimulating motor activity. Subcutaneous pretreatment with mecamylamine (1.0 mg kg-1) completely prevented the locomotor stimulant action of nicotine in tolerant rats, whereas chlorisondamine (0.01 or 0.1 mg kg-1 s.c.) only partially reduced it. When mecamylamine was given after an injection of nicotine, the locomotor stimulant action of nicotine was blocked, and nicotine actually reduced activity. A single intraventricular dose of chlorisondamine (2 micrograms) blocked the stimulant actions of nicotine for the duration of the experiment (23-24 days).

Full text

PDF
587

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aceto M. D., Bentley H. C., Dembinski J. R. Effects of ganglion blocking agents on nicotine extensor convulsions and lethality in mice. Br J Pharmacol. 1969 Sep;37(1):104–111. doi: 10.1111/j.1476-5381.1969.tb09527.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ascher P., Large W. A., Rang H. P. Studies on the mechanism of action of acetylcholine antagonists on rat parasympathetic ganglion cells. J Physiol. 1979 Oct;295:139–170. doi: 10.1113/jphysiol.1979.sp012958. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Clarke P. B., Kumar R. Nicotine does not improve discrimination of brain stimulation reward by rats. Psychopharmacology (Berl) 1983;79(2-3):271–277. doi: 10.1007/BF00427826. [DOI] [PubMed] [Google Scholar]
  4. Clarke P. B., Kumar R. The effects of nicotine on locomotor activity in non-tolerant and tolerant rats. Br J Pharmacol. 1983 Feb;78(2):329–337. doi: 10.1111/j.1476-5381.1983.tb09398.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Domino E. F., Lutz M. P. Tolerance to the effects of daily nicotine on rat bar pressing behavior for water reinforcement. Pharmacol Biochem Behav. 1973 Jul-Aug;1(4):445–448. doi: 10.1016/0091-3057(73)90011-7. [DOI] [PubMed] [Google Scholar]
  6. Hazell P., Peterson D. W., Laverty R. Brief communication. Inability of hexamethonium to block the discriminative stimulus (SD) property of nicotine. Pharmacol Biochem Behav. 1978 Jul;9(1):137–140. doi: 10.1016/0091-3057(78)90025-4. [DOI] [PubMed] [Google Scholar]
  7. Hendry J. S., Rosecrans J. A. The development of pharmacological tolerance to the effect of nicotine on schedule-controlled responding in mice. Psychopharmacology (Berl) 1982;77(4):339–343. doi: 10.1007/BF00432767. [DOI] [PubMed] [Google Scholar]
  8. Hirschhorn I. D., Rosecrans J. A. Studies on the time course and the effect of cholinergic and adrenergic receptor blockers on the stimulus effect of nicotine. Psychopharmacologia. 1974;40(2):109–120. doi: 10.1007/BF00421360. [DOI] [PubMed] [Google Scholar]
  9. Kumar R., Pratt J. A., Stolerman I. P. Characteristics of conditioned taste aversion produced by nicotine in rats. Br J Pharmacol. 1983 May;79(1):245–253. doi: 10.1111/j.1476-5381.1983.tb10518.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Mansner R. Relation between some central effects of nicotine and its brain levels in the mouse. Ann Med Exp Biol Fenn. 1972;50(4):205–212. [PubMed] [Google Scholar]
  11. Marks M. J., Collins A. C. Characterization of nicotine binding in mouse brain and comparison with the binding of alpha-bungarotoxin and quinuclidinyl benzilate. Mol Pharmacol. 1982 Nov;22(3):554–564. [PubMed] [Google Scholar]
  12. Morrison C. F. Effects of nicotine on operant behaviour of rats. Int J Neuropharmacol. 1967 May;6(3):229–240. doi: 10.1016/0028-3908(67)90010-x. [DOI] [PubMed] [Google Scholar]
  13. Morrison C. F., Goodyear J. M., Sellers C. M. Antagonism by antimuscarinic and ganglion-blocking drugs of some of the behavioural effects of nicotine. Psychopharmacologia. 1969;15(5):341–350. doi: 10.1007/BF00403709. [DOI] [PubMed] [Google Scholar]
  14. Morrison C. F., Stephenson J. A. The occurrence of tolerance to a central depressant effect of nicotine. Br J Pharmacol. 1972 Sep;46(1):151–156. doi: 10.1111/j.1476-5381.1972.tb06857.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Pradhan S. N. Effects of nicotine on several schedules of behavior in rats. Arch Int Pharmacodyn Ther. 1970 Jan;183(1):127–138. [PubMed] [Google Scholar]
  16. Romano C., Goldstein A. Stereospecific nicotine receptors on rat brain membranes. Science. 1980 Nov 7;210(4470):647–650. doi: 10.1126/science.7433991. [DOI] [PubMed] [Google Scholar]
  17. Romano C. Nicotine action on rat colon. J Pharmacol Exp Ther. 1981 Jun;217(3):828–833. [PubMed] [Google Scholar]
  18. STONE C. A., MECKELNBURG K. L., TORCHIANA M. L. Antagonism of nicotine-induced convulsions by ganglionic blocking agents. Arch Int Pharmacodyn Ther. 1958 Nov-Dec;117(3-4):419–434. [PubMed] [Google Scholar]
  19. STONE C. A., TORCHIANA M. L., NAVARRO A., BEYER K. H. Ganglionic blocking properties of 3-methylaminoisocamphane hydrochloride (mecamylamine): a secondary amine. J Pharmacol Exp Ther. 1956 Jun;117(2):169–183. [PubMed] [Google Scholar]
  20. Schwartz R. D., McGee R., Jr, Kellar K. J. Nicotinic cholinergic receptors labeled by [3H]acetylcholine in rat brain. Mol Pharmacol. 1982 Jul;22(1):56–62. [PubMed] [Google Scholar]
  21. Stitzer M., Morrison J., Domino E. F. Effects of nicotine on fixed-interval behavior and their modification by cholinergic antagonists. J Pharmacol Exp Ther. 1970 Feb;171(2):166–177. [PubMed] [Google Scholar]
  22. Stolerman I. P., Fink R., Jarvik M. E. Acute and chronic tolerance to nicotine measured by activity in rats. Psychopharmacologia. 1973 Jun 29;30(4):329–342. doi: 10.1007/BF00429192. [DOI] [PubMed] [Google Scholar]
  23. Tarrab-Hazdai R., Edery H. Adipsia and aphagia elicited by intracerebroventricular injections of antiacetylcholine receptor antibodies. Exp Neurol. 1980 Mar;67(3):670–675. doi: 10.1016/0014-4886(80)90135-1. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES